BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

477 related articles for article (PubMed ID: 28284981)

  • 1. Exosomes from M1-Polarized Macrophages Potentiate the Cancer Vaccine by Creating a Pro-inflammatory Microenvironment in the Lymph Node.
    Cheng L; Wang Y; Huang L
    Mol Ther; 2017 Jul; 25(7):1665-1675. PubMed ID: 28284981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multifunctional nanoparticles co-delivering Trp2 peptide and CpG adjuvant induce potent cytotoxic T-lymphocyte response against melanoma and its lung metastasis.
    Xu Z; Ramishetti S; Tseng YC; Guo S; Wang Y; Huang L
    J Control Release; 2013 Nov; 172(1):259-265. PubMed ID: 24004885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The enhanced antitumor-specific immune response with mannose- and CpG-ODN-coated liposomes delivering TRP2 peptide.
    Lai C; Duan S; Ye F; Hou X; Li X; Zhao J; Yu X; Hu Z; Tang Z; Mo F; Yang X; Lu X
    Theranostics; 2018; 8(6):1723-1739. PubMed ID: 29556352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cationic micelle delivery of Trp2 peptide for efficient lymphatic draining and enhanced cytotoxic T-lymphocyte responses.
    Zeng Q; Jiang H; Wang T; Zhang Z; Gong T; Sun X
    J Control Release; 2015 Feb; 200():1-12. PubMed ID: 25540903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exosomes as potent cell-free peptide-based vaccine. II. Exosomes in CpG adjuvants efficiently prime naive Tc1 lymphocytes leading to tumor rejection.
    Chaput N; Schartz NE; André F; Taïeb J; Novault S; Bonnaventure P; Aubert N; Bernard J; Lemonnier F; Merad M; Adema G; Adams M; Ferrantini M; Carpentier AF; Escudier B; Tursz T; Angevin E; Zitvogel L
    J Immunol; 2004 Feb; 172(4):2137-46. PubMed ID: 14764679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancement of immunity by a DNA melanoma vaccine against TRP2 with CCL21 as an adjuvant.
    Yamano T; Kaneda Y; Huang S; Hiramatsu SH; Hoon DS
    Mol Ther; 2006 Jan; 13(1):194-202. PubMed ID: 16112911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficient Delivery of Tyrosinase Related Protein-2 (TRP2) Peptides to Lymph Nodes using Serum-Derived Exosomes.
    Park O; Choi ES; Yu G; Kim JY; Kang YY; Jung H; Mok H
    Macromol Biosci; 2018 Dec; 18(12):e1800301. PubMed ID: 30407735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exosomes from M1-Polarized Macrophages Enhance Paclitaxel Antitumor Activity by Activating Macrophages-Mediated Inflammation.
    Wang P; Wang H; Huang Q; Peng C; Yao L; Chen H; Qiu Z; Wu Y; Wang L; Chen W
    Theranostics; 2019; 9(6):1714-1727. PubMed ID: 31037133
    [No Abstract]   [Full Text] [Related]  

  • 9. Microdosed Lipid-Coated (67)Ga-Magnetite Enhances Antigen-Specific Immunity by Image Tracked Delivery of Antigen and CpG to Lymph Nodes.
    Ruiz-de-Angulo A; Zabaleta A; Gómez-Vallejo V; Llop J; Mareque-Rivas JC
    ACS Nano; 2016 Jan; 10(1):1602-18. PubMed ID: 26678549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antitumor efficacy of interferon-γ-modified exosomal vaccine in prostate cancer.
    Shi X; Sun J; Li H; Lin H; Xie W; Li J; Tan W
    Prostate; 2020 Aug; 80(11):811-823. PubMed ID: 32427375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Solid-in-Oil Peptide Nanocarriers for Transcutaneous Cancer Vaccine Delivery against Melanoma.
    Wakabayashi R; Sakuragi M; Kozaka S; Tahara Y; Kamiya N; Goto M
    Mol Pharm; 2018 Mar; 15(3):955-961. PubMed ID: 29397746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination Cancer Immunotherapy with Dendritic Cell Vaccine and Nanoparticles Loaded with Interleukin-15 and Anti-beta-catenin siRNA Significantly Inhibits Cancer Growth and Induces Anti-Tumor Immune Response.
    Kheshti AMS; Hajizadeh F; Barshidi A; Rashidi B; Ebrahimi F; Bahmanpour S; Karpisheh V; Noukabadi FK; Kiani FK; Hassannia H; Atyabi F; Kiaie SH; Kashanchi F; Navashenaq JG; Mohammadi H; Bagherifar R; Jafari R; Zolbanin NM; Jadidi-Niaragh F
    Pharm Res; 2022 Feb; 39(2):353-367. PubMed ID: 35166995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altered intracellular sorting signals do not influence the efficacy of genetic melanoma vaccines incorporating helper determinants in mice.
    Brück J; Steitz J; Strand D; Tüting T
    J Gene Med; 2005 May; 7(5):613-20. PubMed ID: 15580620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytotoxic T lymphocytes responding to low dose TRP2 antigen are induced against B16 melanoma by liposome-encapsulated TRP2 peptide and CpG DNA adjuvant.
    Jérôme V; Graser A; Müller R; Kontermann RE; Konur A
    J Immunother; 2006; 29(3):294-305. PubMed ID: 16699372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CpG oligodeoxynucleotides augment antitumor efficacy of folate receptor α based DNA vaccine.
    Qiu Z; Xing L; Zhang X; Qiang X; Xu Y; Zhang M; Zhou Z; Zhang J; Zhang F; Wang M
    Oncol Rep; 2017 Jun; 37(6):3441-3448. PubMed ID: 28498413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of recombinant adenovirus and synthetic peptide for DC-based melanoma vaccination.
    Steitz J; Tormo D; Schweichel D; Tüting T
    Cancer Gene Ther; 2006 Mar; 13(3):318-25. PubMed ID: 16151477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chimeric peptide containing both B and T cells epitope of tumor-associated antigen L6 enhances anti-tumor effects in HLA-A2 transgenic mice.
    Lin SI; Huang MH; Chang YW; Chen IH; Roffler S; Chen BM; Sher YP; Liu SJ
    Cancer Lett; 2016 Jul; 377(2):126-33. PubMed ID: 27130449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymph Node-Targeting Nanovaccine through Antigen-CpG Self-Assembly Potentiates Cytotoxic T Cell Activation.
    Xi X; Zhang L; Lu G; Gao X; Wei W; Ma G
    J Immunol Res; 2018; 2018():3714960. PubMed ID: 30018987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-metastatic immunotherapy based on mucosal administration of flagellin and immunomodulatory P10.
    de Melo FM; Braga CJ; Pereira FV; Maricato JT; Origassa CS; Souza MF; Melo AC; Silva P; Tomaz SL; Gimenes KP; Scutti JA; Juliano MA; Zamboni DS; Câmara NO; Travassos LR; Ferreira LC; Rodrigues EG
    Immunol Cell Biol; 2015 Jan; 93(1):86-98. PubMed ID: 25223833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biodistribution and vaccine efficiency of murine dendritic cells are dependent on the route of administration.
    Eggert AA; Schreurs MW; Boerman OC; Oyen WJ; de Boer AJ; Punt CJ; Figdor CG; Adema GJ
    Cancer Res; 1999 Jul; 59(14):3340-5. PubMed ID: 10416590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.